Related Experiment Video
Updated: Mar 3, 2026
11:07
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
27.1K
Hydroxytyrosol Attenuates LPS-Induced Acute Lung Injury in Mice by Regulating Autophagy and Sirtuin Expression
1Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi. China.
Current Molecular Medicine
|April 22, 2017
Summary
Hydroxytyrosol (HT) protects against acute lung injury (ALI) by up-regulating autophagy and activating the SIRT/MAPK pathway. This natural compound reduces inflammation and lung damage, offering therapeutic potential for acute respiratory distress syndrome.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Pharmacology
Background:
- Acute lung injury (ALI) is a critical condition with significant morbidity and mortality.
- Autophagy plays a complex role in ALI pathogenesis.
- Hydroxytyrosol (HT) is being investigated for its potential therapeutic effects in inflammatory conditions.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying hydroxytyrosol's anti-inflammatory effects in a murine model of acute lung injury.
- To investigate the role of autophagy modulation by hydroxytyrosol in ALI.
- To explore the involvement of the SIRT/MAPK signaling pathway in hydroxytyrosol's protective actions.
Main Methods:
- Establishment of a lipopolysaccharide (LPS)-induced ALI model in male BALB/c mice.
- Administration of hydroxytyrosol (100 mg/kg) prior to LPS challenge.
- Assessment of lung injury markers: wet/dry weight ratios, protein leakage, and bronchoalveolar lavage (BAL) fluid inflammatory cell counts.
- Analysis of inflammatory mediators (TNF-α, IL-1β, IL-6, IL-10, MCP-1), sirtuin (SIRT1/3/6) expression, MAPK activation, and autophagy markers via Western blotting and staining.
- Molecular docking simulations to predict interactions between HT, SIRT, and MAPK.
Main Results:
- Hydroxytyrosol treatment abolished LPS-induced SIRT inhibition, MAPK phosphorylation, and autophagy suppression.
- HT significantly reduced pulmonary edema, inflammatory cell infiltration, lung W/D ratios, and BAL fluid protein and inflammatory cell levels.
- HT effectively regulated LPS-induced inflammatory mediators, including TNF-α, IL-1β, IL-6, IL-10, and MCP-1.
Conclusions:
- Hydroxytyrosol exerts protective effects against lung inflammation in ALI mice by promoting autophagy.
- The observed protective effects are likely mediated through the activation of the SIRT/MAPK signaling pathway.
- This study provides novel insights into the molecular mechanisms of hydroxytyrosol, highlighting its therapeutic potential for acute respiratory distress syndrome.
